Lipidio Pharma is pleased to announce that J. Gordon Foulkes, Ph.D., our CEO, is presenting at the BIOCOM Global Life Sciences Partnering Conference on February 28, 2024 at 2:45 pm.

Dr. Foulkes will deliver a presentation entitled “Targeting Obesity Topically: The Skin as an Endocrine Organ.”

For more information on the conference, visit the Registration – Biocom California.